Fundamental dimension Equity attribute | CHLSYPeer $10.16▼-1.07% Cap $23.21BP/E 27.2x QuantScore59/100 | BABBLeader $0.840.00% Cap $6.10MP/E 9.3x QuantScore70/100 | BRRLYPeer $13.90▼-1.64% Cap $7.62BP/E 26.0x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
63/100 |
73/100 |
76/100 |
Valuation Multiples, PEG & DCF upside | 73/100 | 100/100 | 72/100 |
Health Piotroski, Altman Z, leverage & liquidity | 76/100 | 71/100 | 34/100 |
Growth Revenue / earnings growth & margins | 23/100 | 34/100 | 37/100 |
Sentiment Analyst ratings, targets & revisions | — | — | 37/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 27.2x | 9.3x | 26.0x |
Forward P/E (next FY) | — | — | 39.1x |
EV / EBITDA (TTM) | 16.2x | 4.5x | 11.0x |
Price / Sales | 3.3x | 1.7x | 0.4x |
Price / Free Cash Flow | 24.9x | 8.7x | 2.4x |
PEG ratio | 1.91 | 0.55 | 0.38 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 8 / 9 |
Altman Z-Score | 5.17 (Safe) | 1.41 (Distress) | 2.57 (Grey) |
Total debt / equity | 0.42 | 0.08 | 2.08 |
Quick ratio | 0.8x | 3.7x | 1.2x |
Interest coverage | 15.8x | — | 1.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.2% | -3.0% | +42.4% |
Net income growth YoY | +8.2% | +6.4% | -2.1% |
Gross margin (TTM) | 37.8% | 91.1% | 10.1% |
Operating margin (FY) | 16.6% | 21.0% | 4.3% |
FCF margin (FY) | 4.2% | 11.8% | -2.3% |
5. Trailing price performancePrice change over period |
1M return | -1.4% | -0.2% | +3.4% |
3M return | -9.5% | +2.3% | +4.8% |
6M return | -17.4% | -7.2% | -1.4% |
Year to date | -29.4% | -15.2% | -15.5% |
1Y return | -40.2% | -11.6% | -4.6% |
3Y return | -15.1% | +16.7% | -13.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $113.37 +1015.8% upside | $1.56 +85.9% upside | $-30.00 -315.9% premium |
Wall Street consensus target | — — | — — | $15.10 +8.7% · range $15.10–$15.10 |
Consensus stance | — | — | — |